ARVN insider trading
Open-market stock trades by Arvinas (ARVN) executives and directors: who bought or sold, how many shares, at what price and when.
ARVN insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Loomis David K | VP, Chief Accounting Officer | Sell | 232 | $6.36 | $1.48K |
| Jun 24, 2026 | Saik Andrew | Chief Financial Officer | Sell | 5,696 | $8.16 | $46.47K |
| Jun 17, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | 2,576 | $7.59 | $19.56K |
| May 21, 2026 | Teel Randy | President and CEO | Sell | 2,209 | $9.04 | $19.96K |
| May 11, 2026 | Saik Andrew | Chief Financial Officer | Sell | 11,139 | $9.94 | $110.69K |
| May 11, 2026 | Loomis David K | VP, Chief Accounting Officer | Sell | 1,919 | $9.94 | $19.07K |
| May 11, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | 9,657 | $9.94 | $95.97K |
| May 11, 2026 | Berkowitz Noah | Chief Medical Officer | Sell | 11,108 | $9.94 | $110.38K |
| May 11, 2026 | Teel Randy | President and CEO | Sell | 9,657 | $9.94 | $95.97K |
| Mar 18, 2026 | Berkowitz Noah | Chief Medical Officer | Sell | 6,435 | $11.10 | $71.43K |
| Mar 6, 2026 | Morrison Briggs | director | Buy | 20,000 | $13.40 | $268.07K |
| Feb 27, 2026 | Houston John G | director | Sell | 4,688 | $13.24 | $62.07K |
| Feb 27, 2026 | Houston John G | director | Sell | 18,822 | $13.24 | $249.20K |
| Feb 27, 2026 | Houston John G | director | Sell | 11,787 | $13.14 | $154.88K |
| Feb 23, 2026 | Loomis David K | Chief Accounting Officer | Sell | 1,108 | $12.16 | $13.47K |
| Feb 23, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | 1,038 | $12.16 | $12.62K |
| Feb 23, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | 2,571 | $12.16 | $31.26K |
| Feb 23, 2026 | Teel Randy | President and CEO | Sell | 1,038 | $12.16 | $12.62K |
| Feb 23, 2026 | Teel Randy | President and CEO | Sell | 3,748 | $12.16 | $45.58K |
| Feb 13, 2026 | Teel Randy | President and CEO | Sell | 4,403 | $11.89 | $52.35K |
| Feb 13, 2026 | Saik Andrew | Chief Financial Officer | Sell | 5,134 | $11.89 | $61.04K |
| Feb 13, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | 4,592 | $11.89 | $54.60K |
| Feb 13, 2026 | Berkowitz Noah | Chief Medical Officer | Sell | 5,685 | $11.89 | $67.59K |
| Feb 13, 2026 | Loomis David K | Chief Accounting Officer | Sell | 1,016 | $11.89 | $12.08K |
| Nov 7, 2025 | Loomis David K | Chief Accounting Officer | Sell | 230 | $9.89 | $2.27K |
| Sep 22, 2025 | Morrison Briggs | director | Buy | 30,000 | $7.57 | $227.01K |
| Jun 24, 2025 | Saik Andrew | Chief Financial Officer | Sell | 5,700 | $7.61 | $43.38K |
| Jun 17, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 2,583 | $7.49 | $19.35K |
| Mar 18, 2025 | Berkowitz Noah | Chief Medical Officer | Sell | 8,658 | $8.59 | $74.37K |
| Feb 24, 2025 | Loomis David K | Chief Accounting Officer | Sell | 1,214 | $16.75 | $20.33K |
| Feb 24, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 3,061 | $16.75 | $51.27K |
| Feb 24, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 1,146 | $16.55 | $18.97K |
| Feb 24, 2025 | Taylor Ian | President, R&D | Sell | 7,356 | $16.75 | $123.21K |
| Feb 24, 2025 | Taylor Ian | President, R&D | Sell | 1,664 | $16.55 | $27.54K |
| Feb 24, 2025 | Houston John G | President and CEO | Sell | 26,184 | $16.75 | $438.58K |
| Feb 24, 2025 | Houston John G | President and CEO | Sell | 5,154 | $16.55 | $85.30K |
- ARVN insiders bought $495.08K and sold $2.32M in open-market trades over their last 36 filings.
Updated 2026-11-18 05:48 UTC